Harrow Health, Inc. (NASDAQ:HROW) headquartered in San Diego, will host a conference call for the investment community to discuss the 3Q20 earnings result on 9th November 2020 at 4:45 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.harrowinc.com
Earnings Expectation
Harrow Health, Inc. is reporting third quarter earnings results on Monday 9th November 2020, after market close.
The consensus estimates from Thomson Reuters are income of $ 0.03 per share from $ 9.34 million in revenue. For the full year, analysts predict revenues of $ 41.93 million, while looking forward to loss of $ 0.47 per share.
Harrow Health, Inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the United States. The company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. It also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.
